Thyrocare Technologies Limited: September ’21 Results Update
Moneylife Digital Team 19 November 2021
Thyrocare Technologies Limited (Thyrocare) came out with a good set of numbers for Q2FY21-22, helped by one-time government contracts related to COVID tests where government also bore the cost of consumables, thus, adding to top- as well as bottom-line. This enabled the company to achieve highest-ever sales, EBITDA (earnings before interest, taxes, depreciation and amortisation) and EBITDA...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Already a subscriber ? Log in
Metropolis Healthcare Limited: September ’21 Results Update
Moneylife Digital Team 18 November 2021
We covered Metropolis Healthcare Limited (MTHL) in detail a month ago here. It came out with its quarterly earnings recently. With COVID second wave abating, it achieved small revenue growth and lower operating margin. It seems on...
Astral Limited: September ’21 Results Update
Moneylife Digital Team 17 November 2021
Astral Limited (Astral) reported overall strong performance in Q2FY21-22, after a subdued Q1FY21-22, following the second wave COVID-related impact. Both, pipes and adhesives, divisions performed well. In fact, the company achieved...
Neogen Chemicals: September ’21 Results Update
Moneylife Digital Team 17 November 2021
Bucking the trend of chemicals companies reporting huge margin compression and decline in operating profit sequentially, Neogen Chemicals (Neogen) posted strong quarterly results. We had earlier written about Neogen in detail here....
Acrysil Ltd: September ’21 Results Update
Moneylife Digital Team 17 November 2021
Acrysil reported gross quarterly revenue of Rs119 crore, up 21.4% quarter-on-quarter (q-o-q). Operating profit and net profit were Rs26 crore and Rs18 crore, up 24% q-o-q and 38% q-o-q, respectively, thanks to strong demand in...
Free Helpline
Legal Credit
Feedback